Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

Hormone replacement therapy can improve skin aging in postmenopausal women.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Finasteride reduces hair growth and is safe for women with excessive hair.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Hirsutism is excessive male-pattern hair growth mainly caused by ovarian hormones, and severe cases may require costly treatment with side effects.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The treatment successfully lowered testosterone levels and reduced symptoms.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Testosterone therapy significantly improved Hidradenitis Suppurativa symptoms.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.